Stock TNXP TONIX PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Tonix Pharmaceuticals Nasdaq

Equities

TNXP

US8902608624

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-02-04 pm EST 		5-day change 1st Jan Change
0.3222 USD -2.36% Intraday chart for Tonix Pharmaceuticals +2.32% -20.05%
Apr. 01 Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Apr. 01 Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Tonix Pharmaceuticals

b486e5128baf51e3b017f3.9XS2t7BBtvY9Oht_foqxVFkkMn5pTI1KnFLNxfefRqA.wSzf58A27KRxeTY9IeL2EBpDfRkIA-MG-A2-_IWqHsG3JNuG2QTRrEtPfA~abe0adb5c86a5ba8edd0c779d62513c6

Upcoming events on Tonix Pharmaceuticals

2024-05-01 11:00 am Planet MicroCap Showcase
2024-05-05 Q1 2024 Earnings Release (Projected)
2024-05-22 11:00 am Annual General Meeting
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-03-16 Q4 2024 Earnings Release (Projected)

Past events on Tonix Pharmaceuticals

2024-04-01 04:15 pm Q4 2023 Earnings Release
2024-03-19 05:45 am BioEurope Spring Conference
2024-03-16 American Chemistry Society Spring Meeting
2024-03-06 Controversies in Fibromyalgia International Congress
2024-03-03 Investor Meeting
2024-02-26 01:30 pm BIO CEO & Investor Conference
2024-02-15 11:00 am Extraordinary Shareholders Meeting
2024-01-31 01:00 pm Investor Meeting - Key Opinion Leader
2024-01-25 11:00 am Extraordinary Shareholders Meeting
2024-01-08 05:00 pm Biotech Showcase
2024-01-07 06:50 pm Sachs Associates Neuroscience Innovation Forum

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		7,77
10,3
-24.56%
17,3

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-28,8
-26,4
-9%		-50,5
-48,0
-5.24%		-92,3
-88,1
-4.82%		-112
-109
-2.59%		-118
-118
-0.45%
-76,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-28,6
-26,2
-9.23%		-50,5
-47,3
-6.69%		-92,3
-92,7
0.45%		-110
-110
-0.2%		-117
-119
1.89%
-80,7

Net income
Million USD		Released
Forecast
Spread 		-31,1
-26,3
-18.25%		-52,2
-48,7
-7.03%		-92,3
-88,0
-4.92%		-117
-111
-5.76%		-117
-115
-1.05%
-75,2

EPS
USD		Released
Forecast
Spread 		-3 866
-3 110
-24.31%		-110
-95,0
-15.79%		-52,0
-49,0
-6.12%		-20,4
-24,2
15.58%		-6,85
-8,37
18.16%
-0,96

Announcement Date24/03/2015/03/2114/03/2213/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		3,99
5,80
-31.22%		3,78
5,13
-26.38%
3,95


3,95


4,50


4,55


4,20

EBIT
Million USD		Released
Forecast
Spread 		-29,6
-25,3
-17.07%		-26,4
-24,1
-9.69%		-23,3
-26,5
11.94%		-29,6
-29,0
-2.04%		-32,7
-29,9
-9.55%		-33,9
-29,0
-16.9%		-29,0
-30,0
3.33%		-28,1
-25,1
-12.07%		-27,3
-26,8
-2.07%














Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-29,6
-30,0
1.49%		-26,4
-24,1
-9.61%		-23,1
-26,5
12.68%		-29,0
-29,0
0.07%		-31,7
-31,5
-0.57%		-33,0
-28,0
-17.88%		-28,4
-29,2
2.89%		-28,0
-28,3
1.15%		-27,3
-29,6
7.7%














Net income
Million USD		Released
Forecast
Spread 		-29,6
-25,2
-17.06%		-26,4
-24,1
-9.61%		-27,4
-26,5
-3.38%		-29,0
-29,0
0.07%		-34,1
-31,5
-8.2%		-33,0
-28,0
-17.88%		-28,4
-29,3
3.22%		-28,0
-24,5
-14.11%		-27,3
-26,1
-4.58%














EPS
USD		Released
Forecast
Spread 		-14,0
-12,0
-16.67%		-10,0
-9,33
-7.14%		-7,63
-9,03
15.57%		-4,31
-6,38
32.35%		-3,50
-5,38
34.88%		-3,25
-3,02
-7.59%		-2,68
-2,02
-32.45%		-1,83
-1,49
-22.82%		-1,82
-1,46
-24.37%
-0,36


-0,23


-0,21


-0,21


-0,20

Announcement Date14/03/2209/05/2208/08/2207/11/2213/03/2308/05/2310/08/2309/11/2301/04/24-----

Upcoming sector events for Tonix Pharmaceuticals

2024-04-28 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
2024-04-28 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
2024-04-28 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
2024-04-28 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
2024-04-29 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
2024-04-29 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
2024-04-30 07:00 am INCYTE CORPORATION: Q1 2024 Earnings Release
More events

Past sector events for Tonix Pharmaceuticals

Today PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
Today BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
Today SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
Today PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
Today TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-25 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-25 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
2024-04-25 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TNXP Stock
  4. TNXP Stock
  5. Calendar Tonix Pharmaceuticals